Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CNL Healthcare Properties (CHTH) EBITDA Margin (2016 - 2025)

CNL Healthcare Properties (CHTH) has 14 years of EBITDA Margin data on record, last reported at 26.31% in Q3 2025.

  • For Q3 2025, EBITDA Margin rose 396.0% year-over-year to 26.31%; the TTM value through Sep 2025 reached 23.49%, up 138.0%, while the annual FY2024 figure was 22.27%, 200.0% up from the prior year.
  • EBITDA Margin reached 26.31% in Q3 2025 per CHTH's latest filing, up from 25.17% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 26.93% in Q2 2024 and bottomed at 5.29% in Q4 2021.
  • Average EBITDA Margin over 5 years is 21.07%, with a median of 21.86% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: tumbled -1386bps in 2021, then surged 1245bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 5.29% in 2021, then soared by 235bps to 17.74% in 2022, then grew by 1bps to 17.86% in 2023, then rose by 16bps to 20.7% in 2024, then grew by 27bps to 26.31% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 26.31% in Q3 2025, 25.17% in Q2 2025, and 22.13% in Q1 2025.